BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 18033858)

  • 1. Autoimmune diseases. The B cell slayer.
    Matthews R
    Science; 2007 Nov; 318(5854):1232-3. PubMed ID: 18033858
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biopharmaceuticals in the treatment of rheumatoid arthritis].
    Baslund B; Bendtzen K
    Ugeskr Laeger; 2008 Jun; 170(24):2108-10. PubMed ID: 18572481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [B cell depletion therapy using anti-CD20 antibodies in rheumatoid arthritis].
    Yukawa N; Mimori T
    Clin Calcium; 2007 Apr; 17(4):569-76. PubMed ID: 17404487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term treatment of rheumatoid arthritis with rituximab.
    Caporali R; Caprioli M; Bobbio-Pallavicini F; Bugatti S; Montecucco C
    Autoimmun Rev; 2009 Jun; 8(7):591-4. PubMed ID: 19393205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstitution of B cells after B cell-depletion therapy: Comment on the article by Leandro et al.
    Teng YK; van Tilborg A; van Laar JM
    Arthritis Rheum; 2006 Sep; 54(9):3062-3; author reply 3063. PubMed ID: 16948141
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic B cell depletion and regeneration in rheumatoid arthritis: emerging patterns and paradigms.
    Silverman GJ
    Arthritis Rheum; 2006 Aug; 54(8):2356-67. PubMed ID: 16868991
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical outcome and B cell depletion in patients with rheumatoid arthritis receiving rituximab monotherapy in comparison with patients receiving concomitant methotrexate.
    Owczarczyk K; Hellmann M; Fliedner G; Röhrs T; Maizus K; Passon D; Hallek M; Rubbert A
    Ann Rheum Dis; 2008 Nov; 67(11):1648-9. PubMed ID: 18854518
    [No Abstract]   [Full Text] [Related]  

  • 8. B-cell depletion in autoimmune diseases. Advances in autoimmunity.
    Guzman Moreno R
    Autoimmun Rev; 2009 Jun; 8(7):585-90. PubMed ID: 19393204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of methotrexate use in a patient with rheumatoid arthritis and multiple sclerosis.
    Li S; Kaur PP; Berney SN
    J Clin Rheumatol; 2008 Aug; 14(4):241-2. PubMed ID: 18766127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
    Goldblatt F; Isenberg DA
    Handb Exp Pharmacol; 2008; (181):163-81. PubMed ID: 18071946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term relief for RA? Potential therapy targets cells that, in rheumatoid arthritis, short circuit and attack the body.
    Health News; 2004 Oct; 10(10):5. PubMed ID: 15584113
    [No Abstract]   [Full Text] [Related]  

  • 12. B cells, be gone--B-cell depletion in the treatment of rheumatoid arthritis.
    Tsokos GC
    N Engl J Med; 2004 Jun; 350(25):2546-8. PubMed ID: 15201410
    [No Abstract]   [Full Text] [Related]  

  • 13. B lymphocyte depletion therapy with rituximab in rheumatoid arthritis.
    Edwards JC; Leandro MJ; Cambridge G
    Rheum Dis Clin North Am; 2004 May; 30(2):393-403, viii. PubMed ID: 15172048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No B cells--no active RA? Advances in B cell depletion in RA--repeated therapy under conditions of clinical practice.
    Dörner T; Burmester GR
    Rheumatology (Oxford); 2007 Apr; 46(4):563-4. PubMed ID: 17337751
    [No Abstract]   [Full Text] [Related]  

  • 15. Rituximab (Rituxan) for rheumatoid arthritis.
    Med Lett Drugs Ther; 2006 Apr; 48(1233):34-5. PubMed ID: 16625143
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of B-lymphocytes in pathogenesis of rheumatoid arthritis].
    Novak S
    Reumatizam; 2007; 54(2):71. PubMed ID: 18351145
    [No Abstract]   [Full Text] [Related]  

  • 17. B cell-targeted therapy in autoimmune disease: rationale, mechanisms, and clinical application.
    Mease PJ
    J Rheumatol; 2008 Jul; 35(7):1245-55. PubMed ID: 18609733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The humoral response in rheumatoid arthritis and the effect of B-cell depleting therapy].
    Thurlings RM; Vos K; Gerlag DM; Tak PP
    Ned Tijdschr Geneeskd; 2006 Jul; 150(30):1657-61. PubMed ID: 16922350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cells in rheumatology--transforming thinking in rheumatoid arthritis.
    Panayi GS; Hainsworth JD
    Rheumatology (Oxford); 2005 May; 44 Suppl 2():ii1-ii2. PubMed ID: 15851521
    [No Abstract]   [Full Text] [Related]  

  • 20. Rituximab treatment of refractory rheumatoid arthritis.
    Summers KM; Kockler DR
    Ann Pharmacother; 2005 Dec; 39(12):2091-5. PubMed ID: 16249269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.